About the Company
Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ZFGN News
Zafgen Enters Oversold Territory
Zafgen, Inc. ZFGN has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when ...
Buy Rating Justified: Larimar Therapeutics’ Advancements Towards FDA Approval for FA Drug Nomlabofusp
Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Larimar Therapeutics (LRMR – Research Report), with a price ...
Buy Rating on Larimar Therapeutics Backed by Promising Drug Progress for Friedreich’s Ataxia
LifeSci Capital analyst Cory Jubinville, PhD has maintained their bullish stance on LRMR stock, giving a Buy rating today. Cory Jubinville, ...
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
Prior to Vividion, Ms. Allen was the Chief Financial Officer at Zafgen, Inc. (now Larimer Therapeutics). Earlier, she was Vice President of Finance and Treasurer, Principal Financial Officer of ...
Jeffrey S. Hatfield's Net Worth
Who is Jeffrey S. Hatfield? Jeffrey S. Hatfield has an estimated net worth of $8.3 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics, Inc.\DE ...
Sweet Baby Inc. Doesn’t Do What Some Gamers Think It Does
Sweet Baby Inc. is not the largest narrative design company in the games industry. Nor is it solely responsible for the characters and stories in recent high-profile releases like Alan Wake 2 ...
Larimar Therapeutics Inc (LRMR) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Snap Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
Starwood Property Trust Inc.
Annaly Capital Management Inc. 6.5% Conv. Pfd. Series G 0.44% Annaly Capital Management Inc. Pfd. Series I 0.32% Annaly Capital Management Inc. 6.95% Cum. Redeem. Pfd. Series F 0.48% ...
STIHL Inc.
This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and ...
Loading the latest forecasts...